ADVFN Logo
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Monte Rosa Therapeutics Inc

Monte Rosa Therapeutics Inc (GLUE)

5.56
0.00
(0.00%)
Closed January 15 4:00PM
0.00
0.00
(0.00%)

Professional-Grade Tools, for Individual Investors.

Key stats and details

Current Price
5.56
Bid
5.29
Ask
5.95
Volume
-
0.00 Day's Range 0.00
3.32 52 Week Range 12.40
Market Cap
Previous Close
5.56
Open
-
Last Trade
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
3,043,153
Shares Outstanding
61,436,740
Dividend Yield
-
PE Ratio
-2.52
Earnings Per Share (EPS)
-2.2
Revenue
-
Net Profit
-135.35M

About Monte Rosa Therapeutics Inc

Monte Rosa Therapeutics Inc is a biopharmaceutical company involved in developing a portfolio of novel small molecule precision medicines that employ the body's natural mechanisms to degrade therapeutically relevant proteins. It has developed a protein degradation platform, called QuEEN, that enable... Monte Rosa Therapeutics Inc is a biopharmaceutical company involved in developing a portfolio of novel small molecule precision medicines that employ the body's natural mechanisms to degrade therapeutically relevant proteins. It has developed a protein degradation platform, called QuEEN, that enables to rapidly identify protein targets and molecular glue degrader, or MGD, product candidates. Show more

Sector
Biological Pds,ex Diagnstics
Industry
Biological Pds,ex Diagnstics
Headquarters
Wilmington, Delaware, USA
Founded
-
Monte Rosa Therapeutics Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker GLUE. The last closing price for Monte Rosa Therapeutics was $5.56. Over the last year, Monte Rosa Therapeutics shares have traded in a share price range of $ 3.32 to $ 12.40.

Monte Rosa Therapeutics currently has 61,436,740 shares outstanding. The market capitalization of Monte Rosa Therapeutics is $341.59 million. Monte Rosa Therapeutics has a price to earnings ratio (PE ratio) of -2.52.

GLUE Latest News

Monte Rosa Therapeutics Provides Corporate Update and Key Anticipated Milestones for 2025

Initial clinical data from Phase 1 SAD/MAD study of VAV1-directed molecular glue degraderย (MGD) MRT-6160 expected in Q1 2025 Additional clinical results from Phase 1/2 study of MRT-2359 in...

Monte Rosa Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference

BOSTON, Jan. 06, 2025 (GLOBE NEWSWIRE) -- Monte Rosa Therapeutics, Inc. (Nasdaq: GLUE), a clinical-stage biotechnology company developing novel molecular glue degrader (MGD)-based medicines...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.86-13.39563862936.426.4755.3810146835.72251534CS
4-2.11-27.50977835727.677.895.3811813536.63948364CS
120.35.703422053235.2612.44.7630431538.97930861CS
261.1626.36363636364.412.43.5215454518.53685228CS
52-0.44-7.33333333333612.43.328753968.195965CS
156-8.93-61.628709454814.4915.8252.444345908.13263591CS
260-16.44-74.72727272732245.562.444001659.54483837CS

GLUE - Frequently Asked Questions (FAQ)

What is the current Monte Rosa Therapeutics share price?
The current share price of Monte Rosa Therapeutics is $ 5.56
How many Monte Rosa Therapeutics shares are in issue?
Monte Rosa Therapeutics has 61,436,740 shares in issue
What is the market cap of Monte Rosa Therapeutics?
The market capitalisation of Monte Rosa Therapeutics is USD 341.59M
What is the 1 year trading range for Monte Rosa Therapeutics share price?
Monte Rosa Therapeutics has traded in the range of $ 3.32 to $ 12.40 during the past year
What is the PE ratio of Monte Rosa Therapeutics?
The price to earnings ratio of Monte Rosa Therapeutics is -2.52
What is the reporting currency for Monte Rosa Therapeutics?
Monte Rosa Therapeutics reports financial results in USD
What is the latest annual profit for Monte Rosa Therapeutics?
The latest annual profit of Monte Rosa Therapeutics is USD -135.35M
What is the registered address of Monte Rosa Therapeutics?
The registered address for Monte Rosa Therapeutics is CORPORATION TRUST CENTER 1209 ORANGE ST, WILMINGTON, DELAWARE, 19801
What is the Monte Rosa Therapeutics website address?
The website address for Monte Rosa Therapeutics is www.monterosatx.com.
Which industry sector does Monte Rosa Therapeutics operate in?
Monte Rosa Therapeutics operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
AALAmerican Airlines Group Inc
$ 18.21
(0.00%)
0
AAGRAfrican Agriculture Holdings Inc
$ 0.1326
(0.00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
$ 71.1249
(0.00%)
0
AADIAadi Bioscience Inc
$ 2.995
(0.00%)
0
AACGATA Creativity Global
$ 0.91995
(0.00%)
0
AALAmerican Airlines Group Inc
$ 18.21
(0.00%)
0
AAGRAfrican Agriculture Holdings Inc
$ 0.1326
(0.00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
$ 71.1249
(0.00%)
0
AADIAadi Bioscience Inc
$ 2.995
(0.00%)
0
AACGATA Creativity Global
$ 0.91995
(0.00%)
0
AALAmerican Airlines Group Inc
$ 18.21
(0.00%)
0
AAGRAfrican Agriculture Holdings Inc
$ 0.1326
(0.00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
$ 71.1249
(0.00%)
0
AADIAadi Bioscience Inc
$ 2.995
(0.00%)
0
AACGATA Creativity Global
$ 0.91995
(0.00%)
0

Your Recent History

Delayed Upgrade Clock